Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.

Selvapandiyan A, Dey R, Nylen S, Duncan R, Sacks D, Nakhasi HL.

J Immunol. 2009 Aug 1;183(3):1813-20. doi: 10.4049/jimmunol.0900276. Epub 2009 Jul 10.

PMID:
19592661
[PubMed - indexed for MEDLINE]
Free Article
2.

Mechanisms of acquired immunity in leishmaniasis.

Howard JG, Liew FY.

Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):87-98. Review.

PMID:
6151691
[PubMed - indexed for MEDLINE]
3.

Leishmaniasis: current status of vaccine development.

Sukumaran B, Madhubala R.

Curr Mol Med. 2004 Sep;4(6):667-79. Review.

PMID:
15357215
[PubMed - indexed for MEDLINE]
4.

Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Okwor I, Uzonna J.

Immunol Res. 2008;41(2):123-36. doi: 10.1007/s12026-008-8016-2. Review.

PMID:
18389179
[PubMed - indexed for MEDLINE]
5.

Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.

Fernandes AP, Coelho EA, Machado-Coelho GL, Grimaldi G Jr, Gazzinelli RT.

Curr Opin Microbiol. 2012 Aug;15(4):476-85. Epub 2012 Jun 13. Review.

PMID:
22698479
[PubMed - indexed for MEDLINE]
6.

Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.

Selvapandiyan A, Dey R, Gannavaram S, Solanki S, Salotra P, Nakhasi HL.

Vaccine. 2014 Jun 30;32(31):3895-901. doi: 10.1016/j.vaccine.2014.05.009. Epub 2014 May 14. Review.

PMID:
24837513
[PubMed - indexed for MEDLINE]
7.

Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.

Gannavaram S, Dey R, Avishek K, Selvapandiyan A, Salotra P, Nakhasi HL.

Front Immunol. 2014 May 23;5:241. doi: 10.3389/fimmu.2014.00241. eCollection 2014. Review.

PMID:
24904589
[PubMed]
Free PMC Article
8.

Vaccination against cutaneous leishmaniasis: current status.

Melby PC.

Am J Clin Dermatol. 2002;3(8):557-70. Review.

PMID:
12358557
[PubMed - indexed for MEDLINE]
9.

Vaccines and vaccination strategies against human cutaneous leishmaniasis.

Okwor I, Uzonna J.

Hum Vaccin. 2009 May;5(5):291-301. Epub 2009 May 12. Review.

PMID:
19221514
[PubMed - indexed for MEDLINE]
Free Article
10.

Immunoactivation and immunopathogeny during active visceral leishmaniasis.

Goto H, Prianti Md.

Rev Inst Med Trop Sao Paulo. 2009 Sep-Oct;51(5):241-6. Review.

PMID:
19893975
[PubMed - indexed for MEDLINE]
Free Article
11.

Balancing immunity and pathology in visceral leishmaniasis.

Stanley AC, Engwerda CR.

Immunol Cell Biol. 2007 Feb-Mar;85(2):138-47. Epub 2006 Dec 5. Review.

PMID:
17146466
[PubMed - indexed for MEDLINE]
12.

Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics.

Kumari S, Kumar A, Samant M, Singh N, Dube A.

Curr Drug Targets. 2008 Nov;9(11):938-47. Review.

PMID:
18991606
[PubMed - indexed for MEDLINE]
13.

Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.

Chang KP, Reed SG, McGwire BS, Soong L.

Acta Trop. 2003 Mar;85(3):375-90. Review.

PMID:
12659975
[PubMed - indexed for MEDLINE]
14.

Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis.

Ravindran R, Ali N.

Curr Mol Med. 2004 Sep;4(6):697-709. Review.

PMID:
15357218
[PubMed - indexed for MEDLINE]
15.

Immunobiology of leishmaniasis.

Sharma U, Singh S.

Indian J Exp Biol. 2009 Jun;47(6):412-23. Review.

PMID:
19634705
[PubMed - indexed for MEDLINE]
16.

Immunopathogenesis of infection with the visceralizing Leishmania species.

Wilson ME, Jeronimo SM, Pearson RD.

Microb Pathog. 2005 Apr;38(4):147-60. Review.

PMID:
15797810
[PubMed - indexed for MEDLINE]
17.

Immunity and immunosuppression in experimental visceral leishmaniasis.

Goto H, Lindoso JA.

Braz J Med Biol Res. 2004 Apr;37(4):615-23. Epub 2004 Mar 23. Review.

PMID:
15064826
[PubMed - indexed for MEDLINE]
Free Article
18.

The effector mechanism and vaccination against cutaneous leishmaniasis.

Liew FY.

Behring Inst Mitt. 1991 Feb;(88):239-43. Review.

PMID:
2049044
[PubMed - indexed for MEDLINE]
19.

Cutaneous leishmaniasis: progress towards a vaccine.

Launois P, Tacchini-Cottier F, Kieny MP.

Expert Rev Vaccines. 2008 Oct;7(8):1277-87. doi: 10.1586/14760584.7.8.1277. Review.

PMID:
18844599
[PubMed - indexed for MEDLINE]
20.

Immunology of canine leishmaniasis.

BarbiƩri CL.

Parasite Immunol. 2006 Jul;28(7):329-37. Review.

PMID:
16842269
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk